Financhill
Sell
31

RVMD Quote, Financials, Valuation and Earnings

Last price:
$39.68
Seasonality move :
7.11%
Day range:
$39.00 - $40.25
52-week range:
$29.17 - $62.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
3.55x
Volume:
2.5M
Avg. volume:
1.9M
1-year change:
5.65%
Market cap:
$7.4B
Revenue:
$11.6M
EPS (TTM):
-$4.00

Earnings Data

Next earnings date for RVMD
Aug 07
2025
Most recent earnings per share
-$1.13
Missed by $0.07
(May 7/2025)
Consensus Estimate
-$1.06
(May 7/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RVMD Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/07/2025 Q2 $500K -- -- -$1.12 --
05/07/2025 Q1 -- -- -$1.13 -$1.06 -$0.07
02/26/2025 Q4 $346.2K -- -$1.12 -$0.96 -$0.16
11/06/2024 Q3 $346.2K -- -$0.94 -$0.88 -$0.06
08/07/2024 Q2 $807.7K -- -$0.81 -$0.76 -$0.05
05/08/2024 Q1 $674.2K -- -$0.70 -$0.72 $0.02
02/26/2024 Q4 $1.2M $742K -$1.21 -$0.88 -$0.33
11/06/2023 Q3 -- -- -$0.99 -$1.00 $0.01
08/08/2023 Q2 -- -- -$0.92 -$0.82 -$0.10
05/08/2023 Q1 -- -- -$0.72 -$0.80 $0.08
02/27/2023 Q4 -- -- -$0.63 -$0.81 $0.18
11/07/2022 Q3 -- -- -$0.87 -$0.85 -$0.02
08/09/2022 Q2 -- -- -$0.82 -$0.84 $0.02
05/09/2022 Q1 -- -- -$0.78 -$0.77 -$0.01
02/28/2022 Q4 -- -- -$0.71 -$0.64 -$0.07
11/10/2021 Q3 -- -- -$0.72 -$0.62 -$0.10
08/11/2021 Q2 -- -- -$0.60 -$0.56 -$0.04
05/10/2021 Q1 -- -- -$0.53 -$0.52 -$0.01
03/02/2021 Q4 -- -- -$0.52 -$0.43 -$0.09
11/12/2020 Q3 -- -- -$0.42 -$0.40 -$0.02
08/10/2020 Q2 -- -- -$0.46 -$0.37 -$0.09
05/14/2020 Q1 -- -- -$0.74 -$0.36 -$0.38
12/31/2019 Q4 -- -- -$0.36 -$0.62 $0.26
09/30/2019 Q3 -- -- -$0.47 -- --
06/30/2019 Q2 -- -- -$0.36 -- --
03/31/2019 Q1 -- -- -$0.35 -- --
12/31/2018 Q4 -- -- -$0.38 -- --

Revolution Medicines Earnings Questions

  • How Much did Revolution Medicines Generate in Revenue Last Quarter?

    Revolution Medicines reported -- worth of top line sales in its most recent quarter.

  • Did Revolution Medicines Beat Earnings Last Quarter?

    Revolution Medicines announced earnings per share of -$1.13 which represents a miss of analyst forecast a -$1.06 per share.

  • Is Revolution Medicines Profitable?

    Revolution Medicines reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Revolution Medicines EPS Next Year?

    Revolution Medicines's earnings are forecast to decrease from -$3.58 per share to -$4.65 per share next year representing a decrease of -29.95%.

  • When is Revolution Medicines's Earnings Date?

    Revolution Medicines's next earnings date is August 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Will Take-Two Stock Go?
How High Will Take-Two Stock Go?

Take-Two Interactive (NASDAQ:TTWO) is the video game development company behind…

Where Will Target’s Stock Be in 10 Years?
Where Will Target’s Stock Be in 10 Years?

If you could hop into a time machine and land…

Why Did Stan Druckenmiller Buy DocuSign?
Why Did Stan Druckenmiller Buy DocuSign?

Billionaire Stanley Druckenmiller’s Duquesne Family Office portfolio is always worth…

Stock Ideas

Buy
64
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
37
RGC alert for Jun 21

Regencell Bioscience Holdings [RGC] is down 40.02% over the past day.

Buy
83
GMS alert for Jun 21

GMS [GMS] is up 23.79% over the past day.

Buy
57
QNTM alert for Jun 21

Quantum BioPharma [QNTM] is up 13.82% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock